Science and Technology of Nuclear Installations / 2012 / Article / Tab 4

Research Article

Major Achievements and Prospect of the ATLAS Integral Effect Tests

Table 4

Test matrix for the cold leg SBLOCA tests.

Test IDBreak sizeSI injectionRemark
APR1400 (%/inch)

SB-CL-011.78%/4SIP-1, 3 and 4 SITs
SB-CL-024.0%/6SIP-1, 3 and 4 SITsClosed core bypass path
SB-CL-037.11%/8SIP-1, 3 and 4 SITs
SB-CL-048.03%/8.5SIP-1, 3 and 4 SITs
SB-CL-051.78%/4SIP-1, 3 and 4 SITsRepeat of SB-CL-01
SB-CL-064.0%/6SIP-2 and SIT-1, 2, 3CPT for SB-DVI-09
SB-CL-070.44%/2SIP-1, 3 and 4 SITsNo loop seal
SB-POSRV-012 POSRV/3.5SIP-1, 3IOPOSRV
SB-POSRV-021 POSRV/2.3SIP-1, 3IOPOSRV
SB-CL-084.0%/6SIP-1, 3 and 4 SITsCold leg injection
SB-CL-094.0%/6SIP-1, 3 and 4 SITs
SB-CL-105.0% (LSTF)4 SITs (CLI)CPT for LSTF SB-CL-18 test

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.